Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Schramm Vern Lee Create: Alert

All | News | Filings
Date FiledTypeDescription
01/03/2022 4 Schramm Vern Lee (Director) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 34,482 options to buy @ $1.45, valued at $50k
01/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/07/2020 4 Schramm Vern Lee (Director) has filed a Form 4 on AzurRx BioPharma, Inc.
Txns: Granted 80,000 options @ $0.97, valued at $77.6k
03/13/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/01/2019 4 Schramm Vern Lee (Director) has filed a Form 4 on AzurRx BioPharma, Inc.
Txns: Granted 7,500 shares @ $0.6, valued at $4.5k
07/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2019 4 Schramm Vern Lee (Director) has filed a Form 4 on AzurRx BioPharma, Inc.
Txns: Granted 30,000 shares @ $0
04/29/2019 4 Schramm Vern Lee (Director) has filed a Form 4 on AzurRx BioPharma, Inc.
Txns: Granted 7,500 shares @ $2.42, valued at $18.2k
01/02/2019 4 Schramm Vern Lee (Director) has filed a Form 4 on AzurRx BioPharma, Inc.
Txns: Granted 7,500 shares @ $1.29, valued at $9.7k
10/01/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/16/2018 4 Schramm Vern Lee (Director) has filed a Form 4 on AzurRx BioPharma, Inc.
Txns: Granted 7,500 shares @ $0
04/02/2018 4 Schramm Vern Lee (Director) has filed a Form 4 on AzurRx BioPharma, Inc.
Txns: Granted 7,500 shares @ $3.14, valued at $23.6k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy